The webinars will be available as live podcasts and will also be able to be viewed on demand on the Dechra Academy.
In the strangles webinar, Dave Rendle, Gayle Hallowell and Richard Newton will explore the current landscape of strangles control, focusing on the role of vaccination, testing and quarantine measures.
In the disease prevention webinar, Gayle Hallowell, Dave Rendle, Tamzin Furtado and others will give an insight into chronic disease management and preventative vaccination to improve uptake and optimise treatment outcomes.
Both webinars broadcast from 8pm GMT, with a live Q&A session from 8:45pm, finishing at 9:15pm GMT.
https://membership.elearning.vet/Dechra-equine-medicine-series.
Langford Veterinary Services, a fully owned subsidiary of the University of Bristol, has announced the opening of a new standing equine magnetic resonance imaging (MRI) facility at the university's equine centre.
The equine MRI facility completes the diagnostic imaging facilities in the School, which include a 16-slice CT scanner for small animals and standing horses, digital radiography, high-resolution fluoroscopy, diagnostic ultrasound, echocardiography and scintigraphy with a high-resolution 1.5 tesla MRI scanner, available seven days a week.
Evita Busschers, Senior Teaching Fellow and orthopaedic surgeon in the equine centre, said: “We are very grateful to the Trustees of the Alborada Trust and the Langford Trust who have provided generous support for the MRI facility. The new imaging facility will enable us to provide an even better and more complete service for our equine patients and completes the diagnostic imaging facilities available at the centre.
“Equine MRI offers the ability to image soft tissue structures and identify soft tissue injuries that cannot be demonstrated with other diagnostic imaging modalities and therefore has major additional value in providing a diagnosis and prognosis in lameness evaluations.”
Miles Littlewort, a trustee from the Alborada Trust added: “Donating the money is the easy bit but ensuring that it has been used where it should be and that it has made the necessary difference is much more challenging. We are so pleased to have had the opportunity to support the Langford Trust and their work to improve animal health and welfare. We are delighted to have attended the opening, to meet the clinicians who will use the magnificent facility and to learn about the clinical research which gives all veterinary surgeons evidence-based information to enhance diagnosis and treatment for all patients.”
The new resources include:
Celia Marr, chair of BEVA’s infectious disease working group, said: “Equine disease prevention and management are fundamental for responsible equine health, welfare and performance.
“These resources cover the need-to-know information and are all in one easy reverence location on the newly designed infection control page on the BEVA website.”
https://www.beva.org.uk/Resources/Equine-infectious-diseases
Vet Stuart Thorne from Fellowes Farm Equine Clinic in Abbots Ripton has praised the work of the charity-run National Foaling Bank after it helped save the life of an orphan three day old filly foal.
A research project funded by The Horse Trust has found that various types of ocular tumours can be successfully treated with mitomycin C, a cytotoxic antibiotic isolated from a bacterium.
The research concludes that mitomycin C offers a safe and cost effective alternative to current treatment options such as surgery and radiation.
The research project was led by Fernando Malalana, while working as The Horse Trust's Clinical Scholar in Equine Internal Medicine at University of Liverpool. Fernando is now working as a Clinician Teacher in Equine Internal Medicine at the university.
Ocular tumours are more difficult to treat than tumours in other parts of the horse's body due to the risk of damaging the eye. In the study, Malalana investigated the use of mitomycin C in treating ocular squamous cell carcinoma, the most common ocular tumour in horses, and occular sarcoids, skin tumors that frequently affect the eyelids .
Mitomycin C is an antibiotic isolated from a bacterium, Streptomyces caespitosus. It is known to have cytotoxic effects and has been used to treat tumours in horses before, but only in combination with surgery.
Currently, the main method of treating ocular squamous cell carcinoma is by removing the tumour surgically or with radiation. Both treatments are costly and have a number of associated risks. There is also the risk of damage or scarring to the eye.
Fourteen horses with ocular squamous cell carcinoma, three of which were affected bilaterally, were included in the study. Mitomycin C was applied to the conjunctival sac of the affected eye; in some of the cases the treatment was combined with surgery. Malalana found that of the 8 eyes treated with mitomycin C alone, clinical resolution occurred in 6 cases. Of the 9 eyes treated with both surgery and mitomycin C, clinical resolution occurred in 7 cases.
Mitomycin C was also used to treat various types of sarcoids found in the eye. Currently, the most effective treatment for occular sarcoids is radioactive wire. However, radioactive wire treatment is not ideal as it is expensive, only offered in two locations in the UK, and has potential health risks to the vet applying the wire due to exposure to radioactivity.
Six horses and two donkeys with occular sarcoids, including one horse that was affected bilaterally, were treated with mitomycin C, which was injected directly into the tumour. Malalana found that of the nine nodular and fibroplastic occular sarcoids treated with the antibiotic, all were completely cleared. However, the vets did not have good results with verrucous sarcoids.
Malalana said: "The results of this research should offer hope to the owners of horses that have eye tumours. We have already been contacted by vets from across Europe to find out more information about this treatment and hope that it will be offered to more horses with occular tumours in the future".
Vets at the University of Liverpool are now testing the use of mitomycin C on other tumours that are difficult to treat surgically, including melanomas near the horse's anus. So far, two cases have been treated, but it is too early to tell whether treatment has been successful.
Malalana's research has been submitted to Veterinary Ophthalmology journal.
Kate Blakeman has become President Elect and James Crabtree, Junior Vice President.
Imogen (pictured) graduated from the RVC in 2000 and became a first opinion equine vet.
She was awarded RCVS Equine Medicine Advanced Practitioner status in 2014 and gained her Post Graduate Certificate in Veterinary Professional Studies and Stud Medicine Certificate in 2023.
Whilst working full-time in first opinion equine practice, she performs several other roles: VetGDP advisor, veterinary undergraduate teaching and examining, and RCVS Advanced Practitioner assessor.
Imogen is currently Chair of BEVA’s Ethics and Welfare Committee and a member of BEVA’s Education Committee.
Imogen said: “I have loved my experience on BEVA Council over the past few years, not least as Ethics and Welfare Committee chair.
"I have strong opinions and am brave enough to pop my head above the parapet to encourage conversation around topics I am passionate about.
"As a first opinion equine practitioner I hope I can bring a practical perspective to the table.
"I honestly never thought I would have the opportunity for the prestigious role of President - I hope it will inspire others to put themselves forwards.”
www.beva.org.uk.
Photo: @JasSansi
Boehringer Ingelheim has launched Care and Connect a free online PPID aftercare service for horse owners, designed to help veterinary practices monitor their PPID case load and streamline the case management process.
The new service is part of Boehringer's 'Talk About Laminitis (TAL)' Awareness campaign.
The company says that PPID is the sixth most frequently encountered disease syndrome affecting equids in the UK1, and the new service should help engage owners and vets post diagnosis, thereby maximising treatment success.
Liz Barrett, equine business manager at Boehringer, said: “PPID is a progressive disease, so it is vital that veterinary surgeons remain at the centre of care, and that horses are monitored carefully following their initial diagnosis. However we recognise the high administrative demand associated with this, and TAL Care and Connect has been designed to reduce this as much as possible.”
TAL Care and Connect will be offered automatically to horse owners who take advantage of this year’s free* ACTH testing scheme, which will be available from July to November. Equine practices can also offer this aftercare service to all owners of previously diagnosed PPID cases.
Owners who join TAL Care and Connect will be able to set up a profile for their horse which allows all their ACTH results to be stored in one place. They will then receive the relevant reminders for follow-up ACTH testing which will make it easier for vets to monitor their patient’s progress over time.
In addition, owners can download an independently-written PPID information pack. Edited by Prof. Catherine McGowan with contributions from Dr Jo Ireland, Prof. Andy Durham, David Rendle and Dr Teresa Hollands, the pack includes advice on monitoring and follow-up ACTH tests, feeding, general care of the PPID patient and the link between laminitis and PPID.
Talk About Laminitis is supported by Redwings, The British Horse Society and World Horse Welfare, and will run from July until the end of October 2015. Horse owners can find out more and obtain their free ACTH voucher code at www.talkaboutlaminitis.co.uk.
For further information contact your local Boehringer territory manager or visit www.talkaboutlaminitis.co.uk.
*Cost of laboratory test
References
A new scholarship on Equine Emergency and Critical Care has been started at a specialist equine hospital in County Kildare, at the heart of Ireland’s horse-racing district. Anna Hollis is the recipient of the scholarship, which is the first of its kind in Europe.
The scholarship gives her the opportunity to specialize in the field of emergency and critical care and to be Board Certified by the American College of Veterinary Emergency and Critical Care (ACVECC). The scholarship has been funded by a grant from Intervet/Schering-Plough Animal Health.
Anna Hollis (BVet Med, MRCVS) will receive the scholarship, for a duration of two years. Hollis just completed a residency in Medicine at the University of Pennsylvania (New Bolton Center) and already has several publications. She will be under the supervision of Kevin Corley (BVM&S PhD DECEIM DACVIM DACVECC MRCVS), an expert in the field of equine medicine and Board Certified by the ACVECC who is in charge of emergency and critical care at a large equine hospital in the Curragh area of County Kildare, Ireland.
Anna Hollis will be spending several rotation periods in various institutions in Europe and the USA, before taking the board examination for the ACVECC. This is the only equine Emergency and Critical Care residency in the European Union that is recognized by the ACVECC and one of the few in the world taking place at a private institution.
Intervet/Schering-Plough Animal Health is supporting this two-year initiative, “We are very excited to be working with Dr. Corley to establish this scholarship,” said Roberto Ragni-Alunni, Global Technical Manager for the equine business in Intervet/Schering-Plough Animal Health. ”The research offers the possibility to reach a rare level of specialization. This will benefit critically ill horses and help push the boundaries of equine medicine even further.”
The project aims to produce evidence to help reduce the risk of musculoskeletal injury, one of the leading causes of morbidity and mortality in racehorses worldwide.
The researchers say that despite significant advances in understanding of injuries that occur in horses on a racecourse, there is currently limited information on injuries that happen during training.
The study aims to identify modifiable risk factors and inform practical, evidence-based recommendations for trainers and equine vets.
Over a three-year period, the RVC-led research team will conduct prospective cohort studies in flat and national hunt (jump) thoroughbreds in training.
The researchers will estimate the incidence of the most common types of musculoskeletal injuries in racehorses in training, including fracture and tendon and joint injuries, develop novel measures of training workload that can be used to monitor training over time, and investigate how training regimes can be optimised to reduce the risk of exercise-induced injury.
The study will also trial the use of wearable technology to establish its practical usefulness for large-scale application in measuring horses’ training workload.
Professor Kristien Verheyen, Professor of Veterinary Clinical Epidemiology at the RVC, said: “This large-scale study will fill key knowledge gaps on injury occurrence in racehorses in training.
"Its findings will directly impact racehorse welfare by identifying opportunities for intervention based on ‘best practice’ in current training regimens to reduce the likelihood of injury.”
https://www.rvc.ac.uk/research/projects/training-injury-prevention-study
The Seller’s Declaration has been revised with the support of British Equestrian (BEF) and British Horse Society (BHS) to make the purchase process more efficient for both buyer and seller.
BEVA says the new Declaration is a more extensive, stand-alone document which the buyer should request from the seller directly before the formal process of the PPE commences.
In this way the seller is obliged to disclose any pertinent information, such as previous lameness, stereotypies, specific management requirements, previous veterinary interventions and details of preventative dental care and worm control, prior to the PPE proceeding.
Lucy Grieve, Veterinary Projects Officer at BEVA, said: “BEVA’s new Seller’s Declaration will iron out the PPE process to make it smoother and more efficient for all three parties involved: buyer, seller and vet.
“The advantage is it cuts out the vet as a middleman… asking if the horse has received any medication, or coughs on dry hay and so on.
“The new Seller’s Declaration means that the seller should declare those things to the buyer straight off.
"If completed in advance, it should give the buyer more robust information on which to base proceeding with the PPE or not.”
https://www.beva.org.uk/Resources/Clinical-resources/PPE-toolkit
Vidas Equine Insulin provides insulin levels in approximately 20 minutes, which the company says will help with the diagnosis and management of Equine Metabolic Syndrome (EMS), commonly associated with insulin dysregulation in horses.
Vidas Equine ACTH provides dysregulation level testing of the adrenocorticotropic (ACTH) hormone related to the development of Equine Cushing’s Disease (aka Pituitary Pars Intermedia Dysfunction - PPID) in about 45 minutes.
Pierre Rouppert, Global Veterinary Product Manager at bioMérieux, said: “Our new endocrinology tests, because of their rapidity and ease of use, will bring clinical value for veterinary practices, directly at the Point of Care.
"Equine Metabolic Syndrome and Cushing’s Disease are chronic conditions that often evade detection in their initial stages, making early testing crucial in achieving proper management and animal care.”
David Smart, Global Veterinary Business Developer at bioMérieux, said: “This dedicated equine immunoassay test for insulin and ACTH represents a transformative step forward in animal care.
"Veterinary practitioners will be able to achieve fast, reliable and cost-effective laboratory grade results that can aid early detection and subsequent diagnosis for two prolific and debilitating medical conditions in horses.
"The fast and accurate results from these two new tests will allow quicker clinical decisions that will ultimately help more horses receive an improved standard of care and reassure horse owners.”
https://www.biomerieux.com/corp/en/our-offer/clinical-products/vidas-equine-insulin.html
The collection, which is free to read until 7th January 2026, explores:
Laura Nath said: “This collection highlights important and exciting work and improves our understanding of arrhythmogenic mechanisms, diagnosis of arrhythmias and recognition of cardiac pathology in both clinical and research settings.”
https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.current-progress-in-equine-cardiology
The new online resources have been compiled by BEVA in collaboration with the RSPCA, World Horse Welfare, the SSPCA and the National Equine Crime Group, together with national Police and Local Authority representatives.
BEVA President Imogen Burrows said: “It can be an intimidating process when visiting an equid without an owner, but our new resources aim to address the potential stress factor and make the rules around the provision of care very clearcut.
“We have produced all the documents the attending vet should need, no matter their location or circumstances.
"Most importantly, if they are attending alone, they will know how to access the right help at the right time, secure in the knowledge that they are following appropriate, validated procedures.”
The resources include a decision tree for quick checking correct procedures, an overview of stakeholder roles and responsibilities, a ‘what if’ section for troubleshooting and an essential contacts registry.
There are also examination and treatment worksheets, and euthanasia certification forms.
Imogen added: “We have put significant thought and effort into producing these new resources, especially from an ambulatory veterinary perspective.
“It should make all the difference for vets, knowing that they have the all the information they need, to hand, In the unlikely event of a callout to an equid of unknown ownership.”
https://www.beva.org.uk/Resources/Clinical-resources/Welfare-toolkit/Managing-equids-of-unknown-ownership